Hypertension Deck 1 Flashcards

1
Q

Nitroprusside (Nipride)

Mechanism of Action

A

♦ A powerful vasodilator relaxes the vascular smooth muscle and produce consequent dilatation of peripheral arteries and veins.

♦ Sodium nitroprusside is more active on veins than on arteries.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hydralazine

(mechanism of action)

A

♦ Causes direct dilation of arterial wall smooth muscle

Hydralazine decreases B/P and reduces cardiac afterload

(result = decreased arterial blood pressure (diastolic more than systolic) and peripheral vascular resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hydralazine

(onset and duration)

A

Hypotensive effects occur 5—30 minutes after an IV dose.

The antihypertensive effects of an IV dose last 2—6 hours on average

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hydralazine

(side effects)

A

♦ Hypotension

♦ Tachycardia

* The hydralazine-induced reflex autonomic response increases heart rate, stroke volume, cardiac output, and left ventricular ejection fraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hydralazine

(indications)

A

Severe Hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hydralazine

(contraindications)

A

(Precautions), None Listed in Protocol

Hydralazine is excreted mainly in the form of metabolites in the urine. (hydralazine should be used with caution in patients with advanced renal damage)

When hydralazine is used in the presence of increased intracranial pressure, lowering of the blood pressure may result in increased cerebral ischemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hydralazine

(adult dose)

A

5mg IV/IO over 2 minutes

may repeat

♦ to Max of 20mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hydralazine

(pediatric dose)

A

Not indicated in current protocols

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hydralazine

(pregnancy safe)

A

Pregnancy Class C

no adequate human studies have examined the effects of this drug on the fetus, the potential risks to the fetus must be weighed against the potential benefits to the mother.

The American Academy of Pediatrics considers hydralazine to be generally compatible with breast-feeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Labetolol

(mechanism of action)

A

Beta Blocker

♦ Competively blocks beta receptors in the heart and blood vessels

minimizes reduction in cardiac output while decreasing B/P

♦ has very little effect on cerebral circulation.

Class II Antiarrhythmic

(**avoid using with cocaine toxicity**)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Labetolol

(onset and duration)

A

Onset: 2-5 min <> Duration: 16-18 hrs

The maximum effect of each intravenous labetalol dose occurs within 5 minutes.

An initial 0.25 mg/kg injection decreases blood pressure by an average of 11/7 mmHg.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Labetolol

(side effects)

A

Dizziness,

lightheaded,

headache,

nausea/vomiting,

chest pain,

shortness of breath,

fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Labetolol

(indications)

A

> Hypertension <

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Labetolol

(contraindications)

A

Bronchial asthma - β2-adrenoceptors promote bronchodilation- (“beta blocker”) - increased risk for status asthmaticus

overt cardiac failure - has negative inotropic effects; can cause acute left ventricular failure given in large doses to pt’s who have impaired function of the left ventricle

cardiogenic shock - due to acute negative inotropic effects

bradycardia - Labetolol slows heart rate

hypotension - slows HR and decreases B/P

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Labetolol

(adult dose)

A

20 mg IO/IV over 2 minutes

→ give additional 20→ 40→ 80 mg q 10 min PRN (in that progression)

Maximum dose of 300 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Labetolol

(pediatric dose)

A

Not indicated in current protocols

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Labetolol

(pregnancy safe)

A

Pregnancy Class C

Use labetalol during pregnancy only if the potential benefit justifies the potential risk to the fetus.

There are no adequate and well-controlled studies of labetalol use in pregnant women.

Use caution when administering labetalol to a breast-feeding woman. Small amounts of labetalol (approximately 0.004% of the maternal dose) are excreted in human milk.

18
Q

Metoprolol (Lopressor)

(mechanism of action)

A

Lopressor is a beta1-selective adrenergic receptor blocker. (often used in pt’s w/ impaired pulmonary function)

(1) reduction in heart rate and cardiac output

(2) reduction of systolic blood pressure,

(3) inhibition of isoproterenol-induced tachycardia,

(4) reduction of reflex orthostatic tachycardia.

♦ Class II Antiarrhythmic

(**avoid in presence of cocaine toxicity**)

19
Q

Metoprolol (Lopressor)

(onset and duration)

A

Onset: Immediate

Half Life: 3 - 7 hrs

Duration: 5 - 8 hrs

After IV infusion over 10 minutes, the maximal beta blockade occurs within 20 minutes.

20
Q

Metoprolol (Lopressor)

(side effects)

A

Hypotension,

Bradycardia,

Headache,

GI discomfort,

Shortness of breath

21
Q

Metoprolol (Lopressor)

(indications)

A

Acute Coronary Syndromes

Hypertesnion

Tachydysrhythmias

22
Q

Metoprolol (Lopressor)

(contraindications)

A

Bradycardia

Heart Block

Cardiogenic Shock/Heart Failure

23
Q

Metoprolol (Lopressor)

(adult dose)

A

5mg IV bolus,

may be repeated two times (_two minutes apart_) while monitoring heart rate, BP, and EKG

24
Q

Metoprolol (Lopressor)

(pediatric dose)

A

Not currently indicated

25
Q

Metoprolol (Lopressor)

(pregnancy safe)

A

Pregnancy Class C

Metoprolol crosses the placenta.

Available data for published studies have not demonstrated an association of adverse developmental outcomes with the maternal use of metoprolol during pregnancy.

26
Q

Cardene / Nicardipine

(mechanism of action)

A

Calcium channel blocker with direct action on arterial and coronary vascular smooth muscle

♦ Vasodilates and increases myocardial oxygen delivery in patients with vasospastic angina

27
Q

Cardene / Nicardipine

(onset and duration)

A

IV: Within minutes (constant infusion)

Duration = IV: ≤8 hours

28
Q

Cardene / Nicardipine

(side effects)

A

Hypotension

29
Q

Cardene / Nicardipine

(indications)

A

♦ Systolic BPm > 180 mHg

OR

♦ Diastolic BP > 110 mmHg

30
Q

Cardene / Nicardipine

(contraindications)

A

PATIENTS WHO HAVE AORTIC VALVE STENOSIS

31
Q

Cardene / Nicardipine

(adult dose)

A

♦ Infusion at 5-15 mg/hr. (25-75 cc/hr.)

(50 mg/250 ml NS =0.2 mg/ml).

Start at 5 mg/hr then î by 2.5 mg up to 15 mg/hr

once target BP is achieved → titrate back down to a target of 3 mg/hr

32
Q

Cardene / Nicardipine

(pediatric dose)

A

Not indicated in current protocol

33
Q

Cardene / Nicardipine

(pregnancy safe)

A

Pregnancy Class C

There are no adequate and well-controlled studies of nicardipine use in pregnant women.

34
Q

Nitroprusside (Nipride)

Onset and Duration

A

Onset: Rapid

Duration: 1 - 10 min after infusion is stoped

35
Q

Nitroprusside (Nipride)

Side Effects

A

Headache / Dizziness / Hypotension / Coma / Dilated Pupils / Diaphoresis / GI Distress / Acidosis / Cyanide Toxicity / Tachycardia

36
Q

Nitroprusside (Nipride)

Indications

A

Hypertension

37
Q

Nitroprusside (Nipride)

Contraindications

A

Hypersensitivity

Compensatory hypertension secondary to AV shunt or aortic insufficiency

38
Q

Nitroprusside (Nipride)

Adult Dose

A

0.5 - 10 mcg/kg/min IV/IO

titrated to goal B/P

(overdosage of nitroprusside can be manifested as excessive hypotension or cyanide toxicity or as thiocyanate toxicity)

39
Q

Nitroprusside (Nipride)

Pediatric Dose

A

Not Indicated for pediatrics

40
Q

Nitroprusside (Nipride)

Pregnancy Safe

A

Pregnancy category C

(prolonged use of large doses of nitroprusside during pregnancy may lead to cyanide toxicity that may be fatal to the fetus, only give if benifits outweigh risks)

41
Q

Treatment Goal is to lower MAP

A

by 20 - 25 % over 30 - 60 mins

42
Q

While treating hypertension, avoid sudden or precipitous changes in MAP of___

A

> 25% or 50 mmHg from known baseline

(maintain MAP > 90)